Health2Sync partners with Taiwan's MOHW to launch online diabetes care program

Taiwanese startup Health2Sync announced their strategic partnership with Taiwan's Ministry of Health and Welfare (MOHW) in bringing online diabetes care nation-wide.

Health2Sync partners with Taiwan’s Ministry of Health and Welfare in Asia’s first government supported online diabetes care program. Health2Sync's mobile App and web management platform raises the effectiveness of diabetes management on a large scale.

Since September 2016, MOHW and Health2Sync together have enabled more than 30 hospitals and clinics to provide real-time tracking and immediate feedback to patients. Health2Sync's hardware-agnostic software reduces the cost and time to administer remote diabetes care significantly, enabling diabetes care to scale quickly and effectively.

While Taiwan has been viewed as having comprehensive social health coverage, diabetes and its complications have always been costly to Taiwan's National Health Insurance. By using Health2Sync's industry-leading Patient Management Platform and automated care functionality, care providers can support patients to effectively control diabetes on a large scale, and benefit the overall health system as well through reduced hospital visits and related expenditures. For patients, risk of long-term complications can be reduced through proper medication regimen and self-management while maintaining a high quality of life.

"To extend the principles of diabetes shared care service, and to allow patients and care providers to battle diabetes together, we want to leverage digital technology and data analytics to provide patients and care providers a mobile App and web management platform that can raise the effectiveness of diabetes management," said Hsiu-Mei Chen , Section Chief, Department of Nursing and Healthcare, Ministry of Health and Welfare . "Through this, we want to motivate patients to self-manage, merge online and offline resources, and enable comprehensive care for diabetes!"

"We commend this initiative taken by MOHW," said Ed Deng , Co-Founder and CEO of Health2Sync. "Health2Sync is excited to be assisting one of the best diabetes care programs in the region, scaling it through technology, and we hope to build on this experience to bring similar models to other countries in Asia."  

Diabetes is recognized as the fastest-growing health problem in the world. Globally, diabetes affects at least 415 million people and over half of them are in Asia . Health2Sync is building similar management programs with partners in Japan , Hong Kong and Thailand .

Dr. Wayne H-H Sheu, Chair of International Diabetes Federation, Western Pacific Region commented:

Digital tools that help personalize treatment strategies for each patient enable precision medicine to come into play in the unrelenting challenge of diabetes.

Dr. Jason S-T Tu, President of Taiwanese Association of Diabetes Educators commented:

While empowering patients is critical, we are constantly seeking tools and methods to further equip diabetes educators.  What MOHW and Health2Sync have done is the first step to closing the loop of patient self-monitoring and providing feedback.

Earlier this year, Health2Sync has also launched blood pressure and weight tracking, in offering patients a complete picture when it comes to self-monitoring and management.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SGLT2 inhibitor canagliflozin shown to improve kidney oxygenation in diabetes patients